Hostname: page-component-76fb5796d-r6qrq Total loading time: 0 Render date: 2024-04-27T21:42:07.512Z Has data issue: false hasContentIssue false

Late diagnosis of attention deficit hyperactivity disorder and cocaine abuse

Published online by Cambridge University Press:  19 July 2023

C. De Andrés Lobo*
Affiliation:
Psychiatry
C. Vallecillo Adame
Affiliation:
Hospital Clínico Universitario de Valladolid, Valladolid
T. Jiménez Aparicio
Affiliation:
Psychiatry
M. Queipo de Llano de la Viuda
Affiliation:
Psychiatry
G. Guerra Valera
Affiliation:
Psychiatry
A. A. Gonzaga Ramírez
Affiliation:
Psychiatry
M. Fernández Lozano
Affiliation:
Psychiatry
N. Navarro Barriga
Affiliation:
Psychiatry
M. J. Mateos Sexmero
Affiliation:
Psychiatry
B. Rodríguez Rodríguez
Affiliation:
Psychiatry
M. Calvo Valcárcel
Affiliation:
Psychiatry
M. Andreo Vidal
Affiliation:
Psychiatry
M. P. Pando Fernández
Affiliation:
Psychiatry
P. Martínez Gimeno
Affiliation:
Psychiatry
I. D. L. M. Santos Carrasco
Affiliation:
Psychiatry, Hospital Universitario Infanta Cristina, Madrid
J. I. Gonçalves Cerejeira
Affiliation:
Psychiatry, Hospital Río Carrión, Palencia, Spain
A. Rodríguez Campos
Affiliation:
Psychiatry
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Adult ADHD diagnosis sometimes represents a challenge for the clinician, due to the comorbid psychiatric diseases that are often associated and which complicate de recognition of the primary symptoms of ADHD. The prevalence of ADHD in adult populations is 2’5% and it is a relevant cause of functional impairment.

Objectives

Presentation of a clinical case of a male cocaine user diagnosed with adult ADHD.

Methods

Literature review on adult ADHD and comorbid substance abuse.

Results

A 43-year-old male who consulted in the Emergency Department due to auditory hallucinosis in the context of an increase in his daily cocaine use. There were not delusional symptoms associated and judgment of reality was preserved. Treatment with olanzapine was started and the patient was referred for consultation. In psychiatry consultations, he did not refer sensory-perceptual alterations anymore, nor appeared any signals to suspect so, and he was willing to abandon cocaine use after a few appointments. He expressed some work concerns, highlighting that in recent months, in the context of a greater workload, he had been given several traffic tickets for “distractions.” His wife explained that he had always been a inattentive person (he forgets important dates or appointments) and impulsive, sometimes interrupting conversations. In the Barkley Adult ADHD Rating Scale he scored 32 points.

He was diagnosed with adult ADHD and treatment with extended-release methylphenidate was started with good tolerance and evolution, with improvement in adaptation to his job and social environment. Since then, the patient has moderately reduced the consumption of drugs, although he continues to use cocaine very sporadically.

Conclusions

Early detection of ADHD and its comorbidities has the potential to change the course of the disorder and the morbidity that will occur later in adults. Comorbidity in adult ADHD is rather the norm than the exception, and it renders diagnosis more difficult. The most frequent comorbidities are usually mood disorders, substance use disorders, and personality disorders. Treatment of adult ADHD consists mainly of pharmacotherapy supported by behavioral interventions. When ADHD coexists with another disorder, the one that most compromises functionality will be treated first and they can be treated simultaneously. The individual characteristics of each patient must be taken into account to choose the optimal treatment.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.